Acsl Ltd.
USPTO PatentsView assignee record - 7 granted patents across 11 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B64U (Unmanned Aerial Vehicles [UAV]; Equipment Therefor).
The verdict
According to USPTO PatentsView, Acsl ranks #34,065 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 11 technology areas.
- #34,065
- of 49,997 US assignees by volume
- Top 22%
- by Innovation Score (45.9/100)
- 11.7
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R34065 · Foreign Corporation #34,065 · 7 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 7 grants
- MID-PACK #34,065/49,997
- PHOTO-FINISH ACG Pam Pharma PVT
- CPC-FOCUS B64U · 11 areas
- INNOV-PAR 45.9/100
- CLAIMS-PAR 11.7 claims/avg
- TYPE-FRNCORP Foreign Corp
- SPAN-YRS 2022–2025 · 4y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: ACG Pam Pharma Technologies PVT. Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Acsl’s 45.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Acsl
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Acsl · this assignee
Acsl · this assignee
46 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Acsl's Innovation Score is 45.9/100 (top 22% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Acsl?
Each dot is one of Acsl’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Acsl’s own 11.7 claims/patent is at or below the 15.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Acsl's grants concentrate
Acsl Ltd. is a focused PatentsView assignee: 11 CPC subclasses with 85.7% of grants classified under B64U (Unmanned Aerial Vehicles [UAV]; Equipment Therefor). Peak complete grant year is 2024 (3 grants) versus a trough of 1 in 2022. By volume, Acsl sits between ACG Pam Pharma Technologies PVT. Ltd. and Actuate Therapeutics Inc..
Acsl's three-year grant acceleration
Acsl Ltd. shows 5 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Acsl's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- ACG Pam Pharma PVT
ACG Pam Pharma Technologies PVT. Ltd.
7 patents
- Achaogen
Achaogen, Inc.
7 patents
- Acro
Acro Inc.
7 patents
- Acrux DDS PTY
Acrux DDS PTY Ltd
7 patents
- Actega Metal Print
Actega Metal Print GMBH
7 patents
- Actian Netherland…
Actian Netherlands B.V.
7 patents
- Active Products
Active Products Inc.
7 patents
- Actuate Therapeut…
Actuate Therapeutics Inc.
7 patents
- Acsl ◀
Acsl Ltd.
7 patents
What this shows Acsl holds 7 patents at rank #34,058, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Acsl
By rank, the assignees closest to #34,058 in granted patent volume.
- ACG Pam Pharma Technologies PVT. Ltd. #34,054 · 7 patents
- Achaogen, Inc. #34,055 · 7 patents
- Acro Inc. #34,056 · 7 patents
- Acrux DDS PTY Ltd #34,057 · 7 patents
- Actega Metal Print GMBH #34,059 · 7 patents
- Actian Netherlands B.V. #34,060 · 7 patents
- Active Products Inc. #34,061 · 7 patents
- Actuate Therapeutics Inc. #34,062 · 7 patents
Leaders in B64U (Unmanned Aerial Vehicles [UAV])
Other assignees with the most granted patents in Acsl's primary technology class.
Acsl's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
46 Top 22% higher than 78% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2022 | 1 | 14.3% |
| 2023 | 1 | 14.3% |
| 2024 | 3 | 42.9% |
| 2025partial year | 2 | 28.6% |
Which technologies does Acsl Ltd. patent most?
Top 11 of 11 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Acsl Ltd.'s patent record in context - here's where to go next.
- Acsl Ltd.'s lead technology class is B64U (Unmanned Aerial Vehicles [UAV]; Equipment Therefor), 85.7% of its portfolio - see every assignee active in that class. Explore B64U
- Ranked #34,065 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Acsl Ltd. against ACG Pam Pharma Technologies PVT. Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 45.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.